跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/3ML - PPB Drug Approval Details
Approvals
/
PPB
/
ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/3ML
Approved
STANDARD
ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/3ML
ASTRAZENECA HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
0d40885b436237b5
Company
ASTRAZENECA HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
0d40885b436237b5
Product Name
ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/3ML
Drug Hk Name
ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/3ML
Registration Code
HK-67383
Company Name
ASTRAZENECA HONG KONG LIMITED
Company Detail Path
/organization/astrazeneca-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2022-03-07
Company Address
UNIT 1-3, 11/F, CHINA TAIPING FINANCE CENTRE, 18 KING WAH RD, NORTH POINT, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
0d40885b436237b5
Type
Standard
Back to PPB Approvals